Rockwell Medical Inc. appointed Stuart Paul as CEO.
The Wixom, Mich.-based biopharmaceutical company had fired its previous CEO and issued restraining orders against him. The company recently reached a settlement agreement with the former CEO and others.
Paul will take charge as CEO from Sept. 4 and will also become a board member. He last served as the corporate officer and vice president of Abbott Laboratories and was responsible for facilitating the acquisition of Alere Inc. by Abbott.
Rockwell focuses on developing therapies for kidney diseases and for patients undergoing dialysis.